Cancer Incidence in Golestan Province: Report of an Ongoing Population-based Cancer Registry in Iran between 2004 and 2008

被引:0
|
作者
Roshandel, Gholamreza [1 ,2 ]
Sadjadi, Alireza [2 ,3 ]
Aarabi, Mohsen [1 ]
Keshtkar, Abbasali [4 ]
Sedaghat, Seyed Mehdi [5 ]
Nouraie, Seyed Mehdi [2 ]
Semnani, Shahryar [1 ]
Malekzadeh, Reza [2 ]
机构
[1] Golestan Univ Med Sci GOUMS, GRCGH, Gorgan, Iran
[2] Tehran Univ Med Sci, DDRC, Tehran, Iran
[3] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands
[4] Univ Tehran Med Sci, Endocrinol & Metab Res Inst, Tehran, Iran
[5] Golestan Univ Med Sci GOUMS, Dept Hlth, Gorgan, Iran
关键词
Cancer registry; esophageal cancer; Golestan; Iran; HIGH-RISK AREA; SQUAMOUS-CELL CARCINOMA; ESOPHAGEAL CANCER; NORTHERN IRAN; ARDABIL; COHORT;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Golestan Province, at the western end of the Asian esophageal cancer (EC) belt in northeastern Iran, was reported to have one of the highest worldwide rates of EC in the 1970s. We have previously shown a declining incidence of EC in Golestan during the last decades. This study reports additional new results from the Golestan Population-based Cancer Registry (GPCR). Methods: The GPCR collected data from newly diagnosed (incident) cancer cases from all 68 public and private diagnostic and therapeutic centers in Golestan Province. CanReg-4 software was used for data entry and analysis based on the guidelines of the International Agency for Research on Cancer (IARC). Age-standardized incidence rates (ASR) of cancers were calculated using the 2000 world standard population. Results: From 2004 through 2008, 9007 new cancer cases were reported to the GPCR. The mean (SD) age was 55.5 (18.6) years, and 54% were diagnosed in men. The ASRs of all cancers were 175.3 and 141.1 per 100,000 person-years for males and females, respectively. Cancers of the stomach (ASR:30.7), esophagus (24.3), and lung (15.4) were the most common cancers in males. In females, breast cancer (ASR:26.9) was followed by malignancies of the esophagus (19.1) and stomach (12.4). The diagnosis of cancer was based on histopathological reports in 71% and on death certificate only in 9% of cases. Conclusions: The EC incidence rate continues to decline in Golestan, while the incidence rates of stomach, colorectal, and breast cancers continue to increase.
引用
收藏
页码:196 / 200
页数:5
相关论文
共 50 条
  • [1] Cancer Incidence and Mortality in Ardabil: Report of an Ongoing Population-Based Cancer Registry in Iran, 2004-2006
    Babaei, M.
    Jaafarzadeh, H.
    Sadjadi, A. R.
    Samadi, F.
    Yazdanbod, A.
    Fallah, M.
    Aghlmandi, S.
    Ramezani, R.
    Haukka, J.
    Hekmat, S. H.
    Didevar, R.
    Shokoohi, B.
    Malekzadeh, R.
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2009, 38 (04) : 35 - 45
  • [2] Lymphomas in Golestan Province of Iran: Results of a Population-based Cancer Registry
    Roshandel, Gholamreza
    Semnani, Shahryar
    Aarabi, Mohsen
    Keshtkar, Abbasali
    Noohi, Amirhossein
    Najafi, Laily
    Besharat, Sima
    Moradi, Abdolvahab
    Kalavi, Khodaberdi
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2011, 12 (01) : 219 - 222
  • [3] Females' esophagus cancer incidence in Golestan Province, Iran (2004)
    Marjani, Abdoljalal
    Kabir, Mohammad Javad
    Semnani, Shahriyar
    Sedaghat, Seyyed Mehdi
    Moghaddamit, Abbas
    INTERNET JOURNAL OF MEDICAL UPDATE, 2008, 3 (02) : 36 - 39
  • [4] Primary Liver Cancer in Golestan Province, Northeastern Iran: 13-Year Experience of Golestan Population-Based Cancer Registry (GPCR)
    Amlashi, Fazel Isapanah
    Ashkbari, Ali
    Amiriani, Taghi
    Norouzi, Alireza
    Poorkhani, Amir Houshang
    Sedaghat, SeyedMehdi
    Livani, Somayeh
    Ashaari, Mohammad
    Sadeghzadeh, Hamideh
    Besharat, Sima
    Semnani, Shahryar
    Roshandel, Gholamreza
    ARCHIVES OF IRANIAN MEDICINE, 2021, 24 (10) : 727 - 732
  • [5] Cancer incidence in the East Azerbaijan province of Iran in 2015–2016: results of a population-based cancer registry
    Mohammad Hossein Somi
    Roya Dolatkhah
    Sepideh Sepahi
    Mina Belalzadeh
    Jabraeil Sharbafi
    Leila Abdollahi
    Azin Nahvijou
    Saeed Nemati
    Reza Malekzadeh
    Kazem Zendehdel
    BMC Public Health, 18
  • [6] The incidence of prostate cancer in Iran: Results of a population-based cancer registry
    Sadjadi, Alireza
    Nooraie, Mehdi
    Ghorbani, Anahita
    Alimohammadian, Masoomeh
    Zahedi, Mohammad-Javad
    Darvish-Moghadam, Sodeif
    Fakheri, Hafez
    Babai, Masood
    Semnani, Shahriar
    Mansour-Ghanaei, Fariborz
    Mohagheghi, Mohammad-Ali
    ARCHIVES OF IRANIAN MEDICINE, 2007, 10 (04) : 481 - 485
  • [7] Cancer incidence in the East Azerbaijan province of Iran in 2015-2016: results of a population-based cancer registry
    Somi, Mohammad Hossein
    Dolatkhah, Roya
    Sepahi, Sepideh
    Belalzadeh, Mina
    Sharbafi, Jabraeil
    Abdollahi, Leila
    Nahvijou, Azin
    Nemati, Saeed
    Malekzadeh, Reza
    Zendehdel, Kazem
    BMC PUBLIC HEALTH, 2018, 18
  • [8] Primary Biliary Tract Cancers in Golestan, Iran: 13-Year Experience of Golestan Population-Based Cancer Registry
    Ashkbari, Ali
    Amlashi, Fazel Isapanah
    Besharat, Sima
    Mofidi, Mostafa
    Amiriani, Taghi
    Fazel, Abdolreza
    Alimadadi, Mehdi
    Salamat, Faezeh
    Sedaghat, Seyed Mehdi
    Livani, Somayeh
    Bagheri, Ali
    Semnani, Shahriyar
    Norouzi, Alireza
    Roshandel, Gholamreza
    ARCHIVES OF IRANIAN MEDICINE, 2023, 26 (09) : 504 - 509
  • [9] Population-based cancer survival in the Golestan province in the northeastern part of Iran 2007-2012
    Nemati, Saeed
    Saeedi, Elnaz
    Roshandel, Gholamreza
    Nahvijou, Azin
    Badakhshan, Abbas
    Akbari, Mahnaz
    Sedaghat, Seyed Mehdi
    Hasanpour-Heidari, Susan
    Hosseinpour, Reza
    Salamat, Faezeh
    Lotfi, Fereshteh
    Khosravi, Ardeshir
    Soerjomataram, Isabelle
    Bray, Freddie
    Zendehdel, Kazem
    CANCER EPIDEMIOLOGY, 2022, 77
  • [10] Cancer incidence in Iran in 2014: Results of the Iranian National Population-based Cancer Registry
    Roshandel, Gholamreza
    Ghanbari-Motlagh, Ali
    Partovipour, Elham
    Salavati, Fereshteh
    Hasanpour-Heidari, Susan
    Mohammadi, Gohar
    Khoshaabi, Mostafa
    Sadjadi, Alireza
    Davanlou, Masoud
    Tavangar, Seyed-Mohammad
    Abadi, Hakimeh
    Asgari, Abasali
    Behrooz, Mohamadreza
    Cheraghi, Maria
    Danechin, Leila
    Dolatkhah, Roya
    Enferadi, Floria
    Esshaghi, Soodabeh
    Farahani, Mohsen
    Farrokhzad, Solmaz
    Fateh, Mansooreh
    Vahedi, Siamak
    Golpazir, Arash
    Hasanzadeh, Mandieh
    Hazar, Narjes
    Hoseini-hoshyar, Hosein
    Izadi, Mohsen
    Jafarnia, Ali
    Jahantigh, Mahdi
    Jalilvand, Ahmad
    Jazayeri, Mehrdad
    Joola, Parvin
    Kazemzadeh, Yasan
    Khalednejad, Maryam
    Kooshki, Maryam
    Madani, Amineh
    Malekpour-afshar, Reza
    Bayat, Amir-Hossein
    Moinfar, Zeinab
    Mohamadifar, Hosein
    Mohamadzadeh, Gholamhasan
    Motidost-komleh, Rita
    Narooei, Mahboobeh
    Niksiar, Sharareh
    Pirnejad, Habibollah
    Poornajaf, Azadeh
    Pourshahi, Gita
    Rahnama, Amir
    Rashidpour, Bahman
    Ravankhah, Zahra
    CANCER EPIDEMIOLOGY, 2019, 61 : 50 - 58